Allurion Technologies (ALURW) Non Operating Income (2022 - 2026)
Allurion Technologies (ALURW) reported Non Operating Income of -$2.3 million for Q1 2026, down 139.86% on a YoY basis from $5.9 million in Q1 2025, and down 606.93% quarter-over-quarter from $462000.0 in Q4 2025.
Allurion Technologies (ALURW) Non Operating Income (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Non Operating Income for 5 years, with the latest figure at -$2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 139.86% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$6.5 million (down 5.29% YoY), and the FY2025 full-year result was $982000.0, down 32.37% from the prior year.
- Non Operating Income for Q1 2026 stood at -$2.3 million, down from $462000.0 in the prior quarter.
- The five-year high for Non Operating Income was $21.1 million in Q3 2024, with the low at -$34.3 million in Q4 2024.
- Historically, Non Operating Income has averaged $134000.0 across 5 years, with a median of $112500.0 in 2023.
- Annual changes were most pronounced in 2023 — Non Operating Income slumped 2924.39% — and 2024, when it soared 8308.54%.
- Allurion Technologies' Non Operating Income stood at $3.1 million in 2022, then soared by 137.61% to $7.4 million in 2023, then plunged by 565.75% to -$34.3 million in 2024, then surged by 101.35% to $462000.0 in 2025, then slumped by 606.93% to -$2.3 million in 2026.
- The last three Non Operating Income figures came in at -$2.3 million (Q1 2026), $462000.0 (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.34 Mn |
| Dec 31, 2025 | 462,000.00 |
| Sep 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -2.34 Mn |
| Mar 31, 2025 | 5.88 Mn |
| Dec 31, 2024 | -34.25 Mn |
| Sep 30, 2024 | 21.15 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 13.46 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Sep 30, 2023 | 389,000.00 |
| Jun 30, 2023 | -8.68 Mn |
| Mar 31, 2023 | -164,000.00 |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | -420,000.00 |
| Jun 30, 2022 | -287,000.00 |